Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$160,992,378
+$42,789,691 QoQ
Shares Held
593,083
+0.3% QoQ
Ownership
0.411%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#42
of 844 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026RAYMOND JAMES FINANCIAL INC holds $1,810,723,119 across 28 Diagnostics & Research names. NTRA ranks #4 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
779,661 | $390,890,837 | |
| 2 | DHR |
Danaher Corp /De/
|
1,515,515 | $288,675,296 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
1,037,428 | $200,451,836 | |
| 4 | NTRA |
Natera, Inc.
This page
|
593,083 | $160,992,378 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
262,791 | $138,343,692 | |
| 6 | DGX |
Quest Diagnostics Inc
|
505,762 | $107,196,254 | |
| 7 | A |
Agilent Technologies, Inc.
|
636,252 | $84,513,350 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
126,182 | $66,824,723 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $160,992,378 | 593,083 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $118,202,687 | 591,043 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $140,712,573 | 614,224 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $104,767,162 | 650,849 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $140,639,507 | 832,482 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $129,195,143 | 913,621 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $146,418,474 | 924,943 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||